This is not the most recent version of the article. View current version (23 MAR 2014)

Intervention Protocol

You have free access to this content

Terbutaline pump maintenance therapy after threatened preterm labour for reducing adverse neonatal outcomes

  1. Saifon Chawanpaiboon1,*,
  2. Malinee Laopaiboon2,
  3. Pisake Lumbiganon3,
  4. Ussanee S Sangkomkamhang4,
  5. Therese Dowswell5

Editorial Group: Cochrane Pregnancy and Childbirth Group

Published Online: 24 OCT 2013

DOI: 10.1002/14651858.CD010800


How to Cite

Chawanpaiboon S, Laopaiboon M, Lumbiganon P, Sangkomkamhang US, Dowswell T. Terbutaline pump maintenance therapy after threatened preterm labour for reducing adverse neonatal outcomes (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 10. Art. No.: CD010800. DOI: 10.1002/14651858.CD010800.

Author Information

  1. 1

    Faculty of Medicine, Siriraj Hospital, Mahidol University, Department of Obstetrics and Gynaecology, Bangkok, Thailand

  2. 2

    Khon Kaen University, Department of Biostatistics and Demography, Faculty of Public Health, Khon Kaen, Thailand

  3. 3

    Khon Kaen University, Department of Obstetrics and Gynaecology, Faculty of Medicine, Khon Kaen, Thailand

  4. 4

    Khon Kaen Hospital, Department of Obstetrics and Gynaecology, Khon Kaen, Thailand

  5. 5

    The University of Liverpool, Cochrane Pregnancy and Childbirth Group, Department of Women's and Children's Health, Liverpool, UK

*Saifon Chawanpaiboon, Department of Obstetrics and Gynaecology, Faculty of Medicine, Siriraj Hospital, Mahidol University, 2 Prannok, Bangkoknoi, Bangkok, 10700, Thailand. siscw@mahidol.ac.th.

Publication History

  1. Publication Status: New
  2. Published Online: 24 OCT 2013

SEARCH

This is not the most recent version of the article. View current version (23 MAR 2014)

References

Additional references

  1. Additional references
  2. References to other published versions of this review
Ananth 2006
Beck 2010
  • Beck S, Wojdyla D, Say L, Betran AP, Merialdi M, Requejo JH, et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bulletin of the World Health Organization 2010;88:31-8.
Callaghan 2006
Chawanpaiboon 2009
  • Chawanpaiboon S, Sutantawibul A, Pimol K, Sirisomboon R, Worapitaksanond S. Preliminary study: comparison of the efficacy of progesterone and nifedipine in inhibiting threatened preterm labour in Siriraj Hospital. Thai Journal of Obstetrics and Gynaecology 2009;17(1):23-9.
Chawanpaiboon 2011
  • Chawanpaiboon S, Wanitpongpan P, Titapant V, Kanokpongsakdi S, Wantanasiri C, Pimol K, et al. Nifidipine for inhibiting threatened preterm labour in Siriraj Hospital. Siriraj Medical Journal 2008;60(3):111-3.
Elliott 2004
  • Elliott JP,  Istwan NB,  Rhea D,  Stanziano G. The occurrence of adverse events in women receiving continuous subcutaneous terbutaline therapy. American Journal of Obstetrics and Gynecology 2004;191(4):1277-82.
Elliott 2013
  • Elliott JP, Morrison JC. The evidence regarding maintenance tocolysis. Obstetrics and Gynecology International 2013;2013:Article ID: 708023.
FDA 2011
  • FDA U.S. Food, Drug Administration. Terbutaline: Label Change - Warnings Against Use for Treatment of Preterm Labor. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm243843.htm (accessed 18 October 2013) 2011, February 17.
Goldenberg 2002
Goldenberg 2008
Guinn 1998
  • Guinn DA,  Goepfert AR,  Owen J,  Wenstrom KD,  Hauth JC. Terbutaline pump maintenance therapy for prevention of preterm delivery: a double-blind trial. American Journal of Obstetrics and Gynecology 1998;179(4):874-8.
Hayes 2008
  • HAYES, Inc. Continuous Subcutaneous Terbutaline Infusion for Treatment of Preterm Labor. Lansdale, PA: Healthcare Technology Brief Publication, 2008.
Higgins 2011
  • Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Hofmeyr 2009
  • Hofmeyr GJ. Antenatal corticosteroids for women at risk of preterm birth: RHL commentary (last revised: 2 February 2009). The WHO Reproductive Health Library. http://apps.who.int/rhl/pregnancy_childbirth/complications/preterm_birth/cd004454_hofmeyrgj_com/en/ (accessed 18 October 2013) 2009.
Iams 2009
  • Iams JD, Romero R, Creasy RK. Preterm labour and birth. In: 566-567 editor(s). Maternal-Fetal Medicine. Saunders Elsevier: sixth, 2009.
Lam 1987
  • Lam F, Graves WK, Peacock WG. The impact of portable tocodynamometry and subcutaneous terbutaline pump therapy on preterm birth in a private obstetrical practice. Proceedings of the ACOG Districts 8th and 9th Meeting; 1987 September; Las Vegas, Nevada, USA. 1987.
Lam 1988
  • Lam F, Gill P, Smith M. Comparison of portable subcutaneous terbutaline pump and oral terbutaline treatment for long-term tocolysis: a randomized clinical trial. Proceedings of 8th Annual Meeting of the Society of Perinatal Obstetricians; 1988 Feb 3-6; Las Vegas, Nevada, USA. 1988:Abstract no: 400.
Lam 1998
  • Lam F, Elliott J, Jones JS, Katz M, Knuppel RA, Morrison J, et al. Clinical issues surrounding the use of terbutaline sulfate for preterm labor. Obstetrical and Gynecological Survey 1998;53(11 Suppl):S85-S95.
Pennell 2007
  • Pennell CE, Jacobsson B, Williams SM, Buus RM, Muglia LJ, Dolan SM, et al. Genetic epidemiologic studies of preterm birth: guidelines for research. American Journal of Obstetrics & Gynecology 2007;196(2):107-18.
Perry 1995
  • Perry KG Jr,  Morrison JC,  Rust OA,  Sullivan CA,  Martin RW,  Naef RW 3rd. Incidence of adverse cardiopulmonary effects with low-dose continuous terbutaline infusion. American Journal of Obstetrics and Gynecology 1995;173(4):1273-7.
RevMan 2012
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
Soloff 2000
Valenzuela 2000
  • Valenzuela GJ, Sanchez-Ramos L, Romero R, Silver HM, Koltun WD, Millar L, et al. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group. American Journal of Obstetrics and Gynecology 2000;182(5):1184.
Vatish 2005
  • Vatish M, Grom K, Bennett P, Thornton S. Preterm labour: managing risk in clinical practice. In: Norman J, Greer I editor(s). Management of Preterm Labour. Cambridge: Cambridge University Press, 2005:192-208.
Wenstrom 1997
  • Wenstrom KD,  Weiner CP,  Merrill D,  Niebyl J. A placebo-controlled randomized trial of the terbutaline pump for prevention of preterm delivery. American Journal of Perinatology 1997;14(2):87-91.

References to other published versions of this review

  1. Additional references
  2. References to other published versions of this review
Nanda 2002
  • Nanda K, Cook LA, Gallo MF, Grimes DA. Terbutaline pump maintenance therapy after threatened preterm labor for preventing preterm birth. Cochrane Database of Systematic Reviews 2002, Issue 4. [DOI: 10.1002/14651858.CD003933]